High-yield tobacco stocks: City has a new favourite

After a strong six months for the sector, a City analyst has downgraded one of the FTSE 100 tobacco giants and upgraded another. Graeme Evans reveals their new top pick.

3rd October 2024 15:16

Graeme Evans from interactive investor

The fading of tailwinds behind the summer re-rating of EU tobacco stocks today prompted a City bank to switch support from British American Tobacco (LSE:BATS) to FTSE 100 rival Imperial Brands (LSE:IMB).

Morgan Stanley thinks fundamentals will be back in focus over the next year after the sector’s run of outperformance due to the preference of investors for defensives over cyclicals.

Invest with ii: What is a Managed ISA? | Open a Managed ISA | Transfer an ISA

The bank has switched BAT from Overweight to Underweight and lowered its price target from 2,850p to 2,500p, with Imperial Brands now Overweight with an improved price objective of 2,300p.

Imperial, which is due to post a year-end trading update on Tuesday, rose 12p this afternoon to 2,154p while BATS weakened 23p to 2,684p.

The high-yielding pair have re-rated by 15-20% so far this year, even though Morgan Stanley noted no sign of improving fundamentals. Near term it sees better visibility on earnings and cash flows at Bristol-based Imperial than BAT.

Its previous Overweight stance on BAT was based on Next Generation Product (NGP) exposure supporting higher growth as smokers increasingly transition.

The bank is now more sceptical on this front and also expects weak US cigarette volumes to persist as smokers downtrade.

It added: “We no longer see BAT benefiting near term from transitioning smokers, given the lack of regulatory enforcement against illicit disposable e-cigarettes, resulting in low-single-digit percentage declines to its US business in 2025/26.”

While admitting that Imperial’s NGP positioning could hinder growth over the longer term, it believes the company’s near-term earnings visibility is better as it has less of a premium cigarette portfolio and has lower exposure to US NGPs.

The bank also highlights Imperial’s superior buyback capability that equates to a potential 25% of its market cap over the next three years, compared with 5% at BAT. This is accompanied by greater certainty around returns due to lower leverage and less near-term litigation risk.

Morgan Stanley concluded: “Following a period of outperformance, our equity strategists are more cautious on defensives. Less top-down support further reinforces being selective on stock allocation, strengthening our preference for Imperial Brands over BAT.”

These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.

Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.

Get more news and expert articles direct to your inbox